Royce & Associates LP reduced its stake in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS - Free Report) by 9.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 341,297 shares of the company's stock after selling 33,742 shares during the quarter. Royce & Associates LP owned about 2.94% of John B. Sanfilippo & Son worth $32,188,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Gamco Investors INC. ET AL lifted its holdings in John B. Sanfilippo & Son by 15.3% during the first quarter. Gamco Investors INC. ET AL now owns 42,675 shares of the company's stock worth $4,520,000 after acquiring an additional 5,650 shares in the last quarter. Summit Global Investments bought a new position in shares of John B. Sanfilippo & Son during the 3rd quarter valued at about $715,000. Hunter Perkins Capital Management LLC grew its position in shares of John B. Sanfilippo & Son by 8.2% in the 3rd quarter. Hunter Perkins Capital Management LLC now owns 83,773 shares of the company's stock valued at $7,901,000 after purchasing an additional 6,331 shares during the period. Price T Rowe Associates Inc. MD increased its stake in John B. Sanfilippo & Son by 2.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,524 shares of the company's stock worth $1,327,000 after purchasing an additional 299 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in John B. Sanfilippo & Son by 90.5% during the 2nd quarter. GAMMA Investing LLC now owns 579 shares of the company's stock worth $56,000 after buying an additional 275 shares during the period. 70.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of John B. Sanfilippo & Son from a "buy" rating to a "hold" rating in a report on Monday, November 4th.
Check Out Our Latest Analysis on John B. Sanfilippo & Son
John B. Sanfilippo & Son Stock Down 0.3 %
NASDAQ:JBSS traded down $0.25 during trading hours on Friday, reaching $82.88. 45,617 shares of the stock were exchanged, compared to its average volume of 63,455. The stock has a market cap of $961.41 million, a PE ratio of 17.80 and a beta of 0.11. John B. Sanfilippo & Son, Inc. has a twelve month low of $79.07 and a twelve month high of $108.96. The firm has a 50 day moving average of $91.90 and a 200 day moving average of $96.37. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.06 and a quick ratio of 0.66.
John B. Sanfilippo & Son (NASDAQ:JBSS - Get Free Report) last announced its earnings results on Tuesday, August 20th. The company reported $0.86 EPS for the quarter. John B. Sanfilippo & Son had a net margin of 4.90% and a return on equity of 17.21%. The business had revenue of $269.57 million during the quarter.
John B. Sanfilippo & Son Company Profile
(
Free Report)
John B. Sanfilippo & Son, Inc, through its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States. The company offers raw and processed nuts, including almonds, pecans, peanuts, black walnuts, English walnuts, cashews, macadamia nuts, pistachios, pine nuts, Brazil nuts, and filberts in various styles and seasonings.
See Also
Before you consider John B. Sanfilippo & Son, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and John B. Sanfilippo & Son wasn't on the list.
While John B. Sanfilippo & Son currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.